Evaluation of the Safety and Immunogenicity of Autologous Thrombosomes in Healthy Human Subjects; A Microdose Escalation Study (Cohorts 1 - 4) and Repeat Microdose Immunogenicity Study (Cohort 5)

Trial Profile

Evaluation of the Safety and Immunogenicity of Autologous Thrombosomes in Healthy Human Subjects; A Microdose Escalation Study (Cohorts 1 - 4) and Repeat Microdose Immunogenicity Study (Cohort 5)

Active, no longer recruiting
Phase of Trial: Phase 0

Latest Information Update: 15 Jun 2016

At a glance

  • Drugs Thrombosomes (Primary)
  • Indications Haemorrhage; Wounds
  • Focus Adverse reactions; First in man
  • Sponsors Cellphire
  • Most Recent Events

    • 10 Jun 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Jul 2016.
    • 10 Jun 2016 Status changed from recruiting to active, no longer recruiting.
    • 28 Jul 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Jan 2016, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top